Medications

Breakthrough alpha-ray treatment of cancer without external radiation

For many years, radioactive iodine which emits beta rays has been used for treatment of thyroid cancer. Generally, 5-year survival rates may exceed 90%. However, some thyroid tumors become resistant to iodine treatment ("iodine-refractory"), ...

Oncology & Cancer

The behavior of therapeutic antibodies in immunotherapy

Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of cancerous white blood cells. However, in the more than 20 years since ...

Oncology & Cancer

How oral cancer acquires radioresistance

A research group led by Associate Professor Ryoji Yoshida and Professor Hideki Nakayama from the Department of Oral and Maxillofacial Surgery in Kumamoto University (Japan) has analyzed the extracellular vesicles (EVs) of ...

Oncology & Cancer

Reducing the side effects of treatment for prostate cancer

New research published in BioMed Central's open access journal BMC Medicine reassessing clinical data from trials, which investigate ways of treating side effects of therapy for prostate cancer, finds that tamoxifen, an anti-estrogen ...

Pediatrics

Working to reduce brain injury in newborns

Research-clinicians at Children's National Health System led the first study to identify a promising treatment to reduce or prevent brain injury in newborns who have suffered hypoxia-ischemia, a serious complication in which ...

page 4 from 12